TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07230964: Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis

Sponsor: Dermed Diagnostics, Inc. · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,107,500

Rescue Site Savings

+$5,347,500

Unlock Full NCT07230964 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07230964 Rescue Dossier →